WellCare's stock jumps 23% after Centene announces merger worth $17.3 billion
Health-care company Centene Corp. CNC, -3.86% on Wednesday announced plans to purchase managed-care provider WellCare Health Plans Inc. WCG, -3.93% St. Louis-based Centene said it would buy WellCare, based in Tampa, Florida, for $305.39 per share, with the deal valued at $17.3 billion. Bloomberg News on Tuesday reported that the health-care companies were in merger talks.
Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Health insurer Centene to buy smaller rival WellCare for $15.27 billionU.S. health insurer Centene will buy smaller rival WellCare Health Plans for $15.27 billion in a cash-and-stock deal.
Consulte Mais informação »
Centene to Buy WellCare Health PlansCentene is buying government-sponsored health-care provider WellCare Health Plans in a deal the companies are valuing at $17.3 billion.
Consulte Mais informação »
Memphis Grizzlies Minority Sale To Kushner Values Team At $1.32 Billion
Consulte Mais informação »
CVS Health CEO on reducing costs: Billions in value opportunity is 'in front of us'Jim Cramer talks with CVS CEO Larry Merlo, who says reducing medical costs with the Aetna merger will unlock billions of dollars in value for the company.
Consulte Mais informação »
Levi Strauss valued at $6.6 billion as IPO prices above targetLevi Strauss & Co is coming back to the stock market after more than three decades with a valuation of $6.6 billion $LEVI
Consulte Mais informação »
Levi Strauss, Valued At $6.6 Billion, Is Making A Comeback As A Public CompanyThe 165-year-old company that invented blue jeans still makes most of its money from men’s pants, but that's changing.
Consulte Mais informação »
Boeing has lost $40 billion-plus in market value since Ethiopia crashBoeing is having a horrible month.
Consulte Mais informação »
Biogen scraps Alzheimer drug trials, wiping $17 billion off its market valueReuters - Biogen and partner Eisai Co Ltd are ending two late-stage trials for t...
Consulte Mais informação »
Memphis Grizzlies Minority Sale To Kushner Values Team At $1.32 Billion
Consulte Mais informação »
Levi Strauss valued at $6.6 billion as IPO prices above targetLevi Strauss & Co fetched a higher price than expected in its initial public off...
Consulte Mais informação »